
Lori Youmshajekian
Science Journalist at Freelance
Freelance science journalist | #SHERP41 @NYU_journalism | words: @sciam @newscientist @abcnews @RetractionWatch @YaleE360 @Medscape and more
Articles
-
2 weeks ago |
retractionwatch.com | Lori Youmshajekian
A prominent Italian pharmacologist under investigation for embezzlement and rigging university contracts has garnered a dozen and a half retractions in the last year for image alterations and duplications. But Salvatore Cuzzocrea, the former rector of the University of Messina, told us he did not agree with the retractions because they were decided “without clear communication,” and that none of the papers had problems that he wasn’t able to reply to.
-
1 month ago |
nationalgeographic.com | Lori Youmshajekian
Fitness influencers claim intense workouts such as HIIT or running can spike cortisol and hinder weight loss, while gentler alternatives like walking keep it in check. But cortisol’s role in exercise is far more than simply “good” or “bad.”Often branded as the “stress hormone,” cortisol is blamed for everything from belly fat to burnout. But it plays a crucial role in keeping the body running.
-
1 month ago |
scientificamerican.com | Lori Youmshajekian
Food recalls seemed relentless in the U.S. last year. Cucumbers, eggs, even big-brand products such as McDonald’s Quarter Pounders and Boar’s Head deli meats were implicated in dozens of foodborne illness cases, leaving many questioning whether their favorite foods were safe to eat.
-
1 month ago |
retractionwatch.com | Lori Youmshajekian
Seven years after investigations uncovered “serious noncompliance” in the collection of biological samples at a California VA hospital, the original whistleblowers say several papers related to the work use these problematic samples and should be retracted. But the principal investigator of the work says there’s no reason to question the findings.
-
1 month ago |
scientificamerican.com | Lori Youmshajekian
The class of weight-loss drugs including semaglutide, sold as Wegovy, have become immensely popular new treatments for obesity. One key factor in their effectiveness is that people need to take them indefinitely—but in practice, many don’t. A recent JAMA Network Open analysis found the vast majority of people quit taking these drugs within two years—such stops in treatment often reverses weight loss and health gains.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 455
- Tweets
- 144
- DMs Open
- Yes

RT @evn_report: Armenia’s conservation success story has led to an unexpected challenge: a growing human-bear conflict. As rangers work to…

RT @CivilNetTV: Women’s representation in the upper levels of Armenia’s government has improved significantly in recent years, going from 1…

RT @WIRED: Women suffer from migraines three times as often as men, and often with more intensity. New research into the role of hormones i…